GraceFinance · Source-backed public company research
GeneDx Holdings Corp. (WGS)
Nasdaq · Services · Services-Health Services
Core research established · 4/4 core data layers currently established
What GeneDx Holdings Corp. does
Unless otherwise stated in this Annual Report or the context otherwise requires, references to: •“GeneDx Holdings” refer to GeneDx Holdings Corp., a Delaware corporation; •“Legacy GeneDx” refer to GeneDx, LLC, a Delaware limited liability company, which we acquired on April 29, 2022 (the “Acquisition”); •“Legacy Sema4” refer to Sema4 OpCo Inc., a Delaware corporation, which consummated the business combination with CM Life Sciences, Inc. (“CMLS”) on July 22, 2021 (the “Business Combination”); •“Fabric Genomics” refer to Fabric Genomics, Inc., a Delaware corporation, which we acquired on May 5, 2025 (the “Merger”); and •“we,” “us” and “our,” the “Company” and “GeneDx” refer, as the context requires, to GeneDx Holdings and its consolidated subsidiaries.
Open the company story
The live GraceFinance page shows source-backed financial changes, management context, guidance, confirmed events, risks, and connected history only when the applicable evidence and relationships have been established. Missing research stays visible instead of being inferred.